Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.680
+0.019 (0.41%)
At close: Feb 21, 2025, 4:00 PM
4.960
+0.280 (5.98%)
After-hours: Feb 21, 2025, 6:01 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $35.71 million as of February 21, 2025. Its market cap has increased by 115.07% in one year.
Market Cap
35.71M
Enterprise Value
23.38M
1-Year Change
115.07%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $35.71M, a decrease of -50.98%. That is a compound annual growth rate of -19.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 35.71M | 9.62% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |